You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,384,310


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,384,310
Title: 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions
Abstract:The present invention is directed to certain 2'-fluoro, 2-substituted purine nucleosides which are toxic to cancerous cell lines.
Inventor(s): Montgomery; John A. (Birmingham, AL), Secrist, III; John A. (Birmingham, AL)
Assignee: Southern Research Institute (Birmingham, AL)
Application Number:07/693,646
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 5,384,310

Introduction to US Patents

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. To understand the scope and claims of a specific patent, it is crucial to delve into the patent application process, the types of patents, and the criteria for patentability[2][5].

Types of Patent Applications

There are three primary types of patent applications: utility, design, and plant patents. The most common type is the utility patent, which covers new and useful processes, machines, manufactures, or compositions of matter, or any new and useful improvement thereof[5].

Patent Application Process

A patent application can be filed as either a provisional or a non-provisional application. A provisional application allows for an early filing date with fewer formal requirements, but a non-provisional application must be filed within 12 months, complying with all statutory requirements. The application includes several documents such as a specification, drawings, oath or declaration, application data sheet, transmittal letter, and fees[5].

Claims in a Patent Application

The claims are the most critical part of a patent application as they define the scope of the patent's protection. The claims must be clear, concise, and supported by the specification. They outline what the inventor considers to be the invention and what they wish to protect[5].

Patent Landscape Analysis

Patent landscape analysis is a comprehensive approach that helps in understanding the patent environment for a particular technology area. It goes beyond individual patentability searches to provide a high-level view of patent saturation, helping businesses and R&D management make strategic decisions about their technology investments[3].

Case Study: US Patent 5,384,310

To illustrate the detailed analysis of the scope and claims of a US patent, let's consider US Patent 5,384,310, though the specific details of this patent are not provided here. Here is a general approach to analyzing such a patent:

Patent Title and Abstract

  • The title and abstract provide a brief overview of the invention. Understanding these sections helps in identifying the core idea and purpose of the patent.

Background of the Invention

  • This section explains the context and prior art related to the invention. It helps in understanding the problem the invention solves and how it differs from existing solutions.

Summary of the Invention

  • This section provides a concise description of the invention, including its key features and how it operates.

Detailed Description of the Invention

  • Here, the inventor provides a detailed explanation of the invention, including drawings and diagrams. This section is crucial for understanding the scope of the claims.

Claims

  • The claims section is where the inventor defines what they consider to be the invention. Each claim must be supported by the specification and drawings. There are independent and dependent claims, with dependent claims building upon the independent claims.

Analyzing the Claims

Independent Claims

  • Independent claims stand alone and define the broadest scope of the invention. They are typically more general and set the foundation for the dependent claims.

Dependent Claims

  • Dependent claims are narrower and build upon the independent claims. They add specific details or limitations to the independent claims, providing additional protection.

Patentability Criteria

For a patent to be granted, the invention must meet the criteria of being useful, novel, and non-obvious. Here’s how these criteria apply:

Usefulness

  • The invention must have a practical application and be capable of being used for its intended purpose.

Novelty

  • The invention must be new and not obvious to others in the same field. It cannot be anticipated by prior art.

Non-Obviousness

  • The invention must be significantly different from existing solutions and not obvious to a person of ordinary skill in the relevant field[5].

Patent Landscape and Strategic Insights

A patent landscape analysis can provide strategic insights into the technology area of the patent. Here are some key points:

Identifying Competitors

  • Analyzing the patent landscape helps in identifying key competitors and their patent portfolios. This can reveal areas of high patent saturation and potential gaps in the market[3].

Technology Trends

  • By mapping patent activities over time, businesses can identify trends and areas where technology is evolving rapidly. This helps in making informed decisions about R&D investments[3].

Abandoned Technologies

  • The analysis can also highlight abandoned technologies, which can indicate areas where companies have shifted their focus. This can be valuable in understanding market dynamics and potential opportunities[3].

Recent USPTO Guidance on AI Patents

For patents involving AI technologies, the USPTO has issued updated guidance effective July 17, 2024. This guidance is crucial for understanding how AI-related inventions are evaluated:

Integration into Practical Applications

  • The guidance emphasizes the importance of integrating judicial exceptions into practical applications. This means that claims must show how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field[4].

AI-Assisted Inventions

  • The method of invention development, including the use of AI, does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring that AI’s role as a tool does not exclude inventions from eligibility[4].

Examples and Case Law

  • The USPTO has provided new examples and integrated recent Federal Circuit decisions to offer up-to-date legal standards and interpretations. This helps in drafting claims that are more likely to avoid section 101 rejections[4].

Key Takeaways

  • Claims Definition: The claims in a patent application define the scope of the patent's protection and must be clear, concise, and supported by the specification.
  • Patentability Criteria: Inventions must be useful, novel, and non-obvious to be granted a patent.
  • Patent Landscape Analysis: This analysis provides strategic insights into technology trends, competitor activities, and market gaps.
  • AI Patents: Recent USPTO guidance emphasizes the integration of judicial exceptions into practical applications and ensures AI-assisted inventions are evaluated on equal footing.

FAQs

Q: What are the main types of patent applications filed with the USPTO?

  • The main types are utility, design, and plant patents, with utility patents being the most common[5].

Q: How important are claims in a patent application?

  • Claims are crucial as they define the scope of the patent's protection and must be supported by the specification[5].

Q: What is the purpose of a patent landscape analysis?

  • It provides a comprehensive view of the patent environment, helping businesses make strategic decisions about their technology investments[3].

Q: How does the USPTO evaluate AI-related inventions?

  • The USPTO evaluates AI-related inventions based on their integration into practical applications and ensures that AI’s role as a tool does not exclude inventions from eligibility[4].

Q: What are the key criteria for an invention to be granted a patent?

  • The invention must be useful, novel, and non-obvious to be granted a patent[5].

Sources

  1. What Is the Probability of Receiving a US Patent? - Emory Law Journal, 2009.
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov.
  3. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP.
  4. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  5. Patents - The Maryland People's Law Library.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,384,310

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,384,310

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0473708 ⤷  Subscribe 300247 Netherlands ⤷  Subscribe
European Patent Office 0473708 ⤷  Subscribe 06C0038 France ⤷  Subscribe
European Patent Office 0473708 ⤷  Subscribe SPC/GB06/040 United Kingdom ⤷  Subscribe
Austria 147751 ⤷  Subscribe
Australia 5831590 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.